Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine
Top Cited Papers
- 27 January 2005
- journal article
- review article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 45 (3), 329-335
- https://doi.org/10.1016/j.jacc.2004.08.067
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Dna-loaded albumin microbubbles enhance ultrasound-mediated transfection in vitroJapanese Journal of Clinical Oncology, 2002
- Influence of injection site, microvascular pressureand ultrasound variables on microbubble-mediated delivery of microspheres to muscleJournal of the American College of Cardiology, 2002
- Quantification of myocardial perfusion and determination of coronary stenosis severity during hyperemia using real-time myocardial contrast echocardiographyJournal of the American Society of Echocardiography, 2001
- Myocardial contrast agents: Recent advances and future directionsProgress in Cardiovascular Diseases, 2001
- Echocardiographic Destruction of Albumin Microbubbles Directs Gene Delivery to the MyocardiumCirculation, 2000
- Interaction of Microbubbles with UltrasoundEchocardiography, 1999
- Delivery of Colloidal Particles and Red Blood Cells to Tissue Through Microvessel Ruptures Created by Targeted Microbubble Destruction With UltrasoundCirculation, 1998
- Basis for detection of stenosis using venous administration of microbubbles during myocardial contrast echocardiography: bolus or continuous infusion?Journal of the American College of Cardiology, 1998
- Direct In Vivo Visualization of Intravascular Destruction of Microbubbles by Ultrasound and its Local Effects on TissueCirculation, 1998
- Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injectionJournal of the American College of Cardiology, 1996